Home > Clinical Trials
Check All Search

Saved trials

RECRUITING
NCT06102824
Organoid-based Functional Precision Therapy for Advanced Breast Cancer
252 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
HER2-negative Breast Cancer


Advanced Breast Cancer
RECRUITING
NCT05824975
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
358 Enrollment(s)
11 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Advanced Solid Tumor
Metastatic Solid Tumor
Soft Tissue Sarcoma (STS)
Platinum-resistant Ovarian Cancer (PROC)
Hepatocellular Carcinoma (HCC)
Colorectal Cancer (CRC)
HER2 Negative Breast Cancer
Cutaneous Melanoma
Renal Cell Carcinoma (RCC)
COMPLETED
NCT04989816
Study of T-DXd Monotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Gastric or GEJ Adenocarcinoma Who Have Received 2 or More Prior Regimens
95 Enrollment(s)
24 Study location(s)
INTERVENTIONAL (PHASE2)
Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
RECRUITING
NCT05965479
Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer
25 Enrollment(s)
14 Study location(s)
INTERVENTIONAL (PHASE2)
Gastrooesophageal Cancer
COMPLETED
NCT03901352
Study of Mirogabalin for Central Neuropathic Pain
300 Enrollment(s)
118 Study location(s)
INTERVENTIONAL (PHASE3)
Central Neuropathic Pain
COMPLETED
NCT02612649
Special Drug Use Surveillance of Irribow in Female Patients
793 Enrollment(s)
34 Study location(s)
OBSERVATIONAL (None)
Diarrhea-predominant Irritable Bowel Syndrome
연구종결
KCT0004754
자가인식 앱 피드백 시스템을 통한 edoxaban 약물 순응도 향상 연구: 무작위대조군연구
500 Enrollment(s)
1 Study location(s)
중재연구 (해당사항없음)
COMPLETED
NCT05149014
Safety, Effectiveness and Quality of Life of Trastuzumab Deruxtecan in Patients with HER2+ Breast Cancer
306 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
HER2-positive Breast Cancer